Rare genetic variants in the sodium-dependent organic anion transporter SOAT ( SLC10A6 ): Effects on transport function and membrane expression

Author(s):  
Josefine Bennien ◽  
Thomas Fischer ◽  
Joachim Geyer
2007 ◽  
Vol 282 (27) ◽  
pp. 19728-19741 ◽  
Author(s):  
Joachim Geyer ◽  
Barbara Döring ◽  
Kerstin Meerkamp ◽  
Bernhard Ugele ◽  
Nadiya Bakhiya ◽  
...  

2015 ◽  
Vol 33 (7_suppl) ◽  
pp. 36-73 ◽  
Author(s):  
Philip W. Kantoff ◽  
Xiaodong Wang ◽  
Wanling Xie ◽  
Mari Nakabayashi ◽  
Mark Pomerantz ◽  
...  

137 Background: Genotypes at three SNPs (rs12422149; rs1789693; rs1077858) within SLCO2B1 were associated with time to progression (TTP) on ADT in the Dana-Farber Cancer Institute (DFCI) Prostate CRIS ADT cohort (J Clin Oncol. 2011 29(18): 2565). Variation at exonic SNP rs12422149 (Gln to Arg) allows more efficient import of DHEAS, enhances AR signaling and cell growth, and as a result, is associated with shorter TTP on ADT. We further externally validated the association of SLCO2B1 variants with TTP on ADT in an independent ADT cohort and estimate their association with overall survival (OS) in both cohorts. Methods: An independent ADT cohort (N=616) was established for validation. TTP was defined using the same criteria as for the original cohort. The associations of genetic variants with TTP on ADT and OS were estimated from multivariable Cox regression and adjusted by known prognostic factors. Effects of one intronic SNP rs1077858 on SLCO2B1 and DHEAS uptake activity were characterized in cell cultures. Results: Association between genotype at rs12422149 and TTP on ADT was confirmed in univariable (P= 0.0187) and multivariable (adjusted HR= 1.31 for GG vs AA/AG, P= 0.0489) analyses. The Median OS from ADT initiation was 6.5 years in all patients (N= 1094, original plus validation cohort). The intronic SNP rs1077858 was significantly associated with the OS from ADT initiation in both univariable (P= 0.0091) and multivariable (adjusted HR= 1.34 for GG vs AA/AG, P= 0.014) analyses. The difference of median OS was 18 months. SLCO2B1 expression in normal prostate tissue carrying the major allele of SNP rs1077858 (AA) was significantly lower than those carrying the risk allele (GG) (Ptrend= 0.0193), suggesting that the association of the SNP rs1077858 with the OS on ADT may be due to its impact on the SLCO2B1 expression. SLCO2B1 knockdown in vitro decreased DHEAS uptake and diminished DHEAS-induced prostate cancer cell growth. Conclusions: Germline variants within SLCO2B1 modulate function or expression of SLCO2B1, subsequently affecting the uptake of androgen precursors and affecting TTP or OS in prostate cancer patients.


2010 ◽  
Vol 299 (4) ◽  
pp. F767-F775 ◽  
Author(s):  
James E. Shima ◽  
Takafumi Komori ◽  
Travis R. Taylor ◽  
Doug Stryke ◽  
Michiko Kawamoto ◽  
...  

Apical reabsorption from the urine has been shown to be important for such processes as the maintenance of critical metabolites in the blood and the excretion of nephrotoxic compounds. The solute carrier (SLC) transporter OAT4 ( SLC22A11) is expressed on the apical membrane of renal proximal tubule cells and is known to mediate the transport of a variety of xenobiotic and endogenous organic anions. Functional characterization of genetic variants of apical transporters thought to mediate reabsorption, such as OAT4, may provide insight into the genetic factors influencing the complex pathways involved in drug elimination and metabolite reclamation occurring in the kidney. Naturally occurring genetic variants of OAT4 were identified in public databases and by resequencing DNA samples from 272 individuals comprising 4 distinct ethnic groups. Nine total nonsynonymous variants were identified and functionally assessed using uptake of three radiolabeled substrates. A nonsense variant, R48Stop, and three other variants (R121C, V155G, and V155M) were found at frequencies of at least 2% in an ethnic group specific fashion. The L29P, R48Stop, and H469R variants displayed a complete loss of function, and kinetic analysis identified a reduced Vmax in the common nonsynonymous variants. Plasma membrane levels of OAT4 protein were absent or reduced in the nonfunctional variants, providing a mechanistic reason for the observed loss of function. Characterization of the genetic variants of reabsorptive transporters such as OAT4 is an important step in understanding variability in tubular reabsorption with important implications in innate homeostatic processes and drug disposition.


Author(s):  
Gary Grosser ◽  
Josefine Bennien ◽  
Alberto Sánchez-Guijo ◽  
Katharina Bakhaus ◽  
Barbara Döring ◽  
...  

2004 ◽  
Vol 384 (1) ◽  
pp. 87-92 ◽  
Author(s):  
Fanfan ZHOU ◽  
Zui PAN ◽  
Jianjie MA ◽  
Guofeng YOU

Human organic anion transporter 4 (hOAT4) belongs to a family of organic anion transporters which play critical roles in the body disposition of clinically important drugs, including anti-HIV therapeutics, antitumour drugs, antibiotics, anti-hypertensives and anti-inflammatories. hOAT4-mediated transport of the organic anion oestrone sulphate in COS-7 cells was inhibited by the histidine-modifying reagent DEPC (diethyl pyrocarbonate). Therefore the role of histidine residues in the function of hOAT4 was examined by site-directed mutagenesis. All five histidine residues of hOAT4 were converted into alanine, singly or in combination. Single replacement of His-47, or simultaneous replacement of His-47/52/83 or His-47/52/83/305/469 (H-less) led to a 50–80% decrease in transport activity. The decreased transport activity of these mutants was correlated with a decreased amount of cell-surface expression, although the total cell expression of these mutants was similar to that of wild-type hOAT4. These results suggest that mutation at positions 47, 47/52/83 and 47/52/83/305/469 impaired membrane expression rather than function. We also showed that, although most of the histidine mutants of hOAT4 were sensitive to inhibition by DEPC, H469A (His-469→Ala) was completely insensitive to inhibition by this reagent. Therefore modification of His-469 is responsible for the inhibition of hOAT4 by DEPC.


Sign in / Sign up

Export Citation Format

Share Document